Diagnostic genomic analysis is prognostic in AYA patients with ALL treated on an MRD-stratified pediatric protocol.

Blood Neoplasia · 2025 · PMC12182849 · PMID 40546727

Europe PMC DOI

hedged sentence

0.4601

closest p · 9.2× alpha

0.4601

boldest claim

The sentences

did not reach statistical significanceP = .4601not close (p > 0.1)

As observed in the complete cohort, patients with T-ALL had a better OS, but this did not reach statistical significance (T-ALL 76.5% vs B-ALL 67.5%; OS, P = .4601; and RFS, P = .539; Figure 2 C-D).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.